AdaptHealth Corp.(AHCO)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,024 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
Unusual Activity in AHCO
Events flagged as statistical outliers against AHCO's own multi-year baseline — not fixed dollar thresholds.
- Insider cluster2026-08-07
2 insiders bought $394,530 of AHCO in 30 days — 2.9σ above this company's 2-year norm
View source filing →
AHCO Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for AdaptHealth Corp. (AHCO), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AHCO at 42.3/100 on a 32-signal composite quality model, placing it at rank #2,024 of 2,962 stocks — the bottom half of the AI-ranked universe. AHCO scores in the top quartile across earnings quality (86.9). Areas of concern include institutional flow (19.9) and profitability (20.2), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), AdaptHealth Corp. reports quarterly revenue of $740.3M, net income of $-133.9M, free cash flow of $-20.9M. Top institutional holders of AHCO by reported 13-F value include OEP CAPITAL ADVISORS, L.P., BlackRock, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), based on the most recent SEC filings. AHCO trades on the Nasdaq exchange and files with the SEC under CIK 1725255. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AHCO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AdaptHealth Corp. directly from SEC EDGAR. AdaptHealth Corp.'s 13F Pro composite quality score has ranged between 42 and 61 since 2021, currently 42.3 — a declining long-term trajectory across 68 quarterly and live scoring snapshots.
Revenue
Q2 2026
$740.3M
Net Income
Q2 2026
$-133.9M
Free Cash Flow
Q2 2026
$-20.9M
ROIC
Q2 2026
-16.8%
D/E Ratio
Q2 2026
1.38
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-0.5% YoYNet Income
-178.3% YoYOperating Income
-65.5% YoYEPS (Diluted)
-185.2% YoYTotal Assets
-3.8% YoYTotal Debt
-12.1% YoYOp. Cash Flow
+11.1% YoYFree Cash Flow
-7.0% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $3.24B -0.5% | $3.26B +1.9% | $3.20B +7.7% | $2.97B +21.0% | $2.45B +132.4% | $1.06B |
| Net Income | $-70.8M -178.3% | $90.4M +113.3% | $-678.9M -1079.4% | $69.3M -55.6% | $156.2M +196.6% | $-161.6M |
| Operating Income | $90.9M -65.5% | $263.7M +144.1% | $-598.4M -414.3% | $190.4M -15.6% | $225.6M +216.2% | $71.3M |
| EPS (Diluted) | $-0.52 -185.2% | $0.61 +111.5% | $-5.31 -1709.1% | $0.33 -50.7% | $0.67 +121.8% | $-3.08 |
| Total Assets | $4.32B -3.8% | $4.49B -0.5% | $4.51B -13.6% | $5.22B -0.6% | $5.25B +189.5% | $1.81B |
| Total Debt | $1.76B -12.1% | $2.00B -9.3% | $2.20B -1.0% | $2.22B -0.0% | $2.22B +180.4% | $792.9M |
| Operating Cash Flow | $601.8M +11.1% | $541.8M +12.7% | $480.7M +28.6% | $373.9M +35.6% | $275.7M +40.9% | $195.6M |
| Free Cash Flow | $219.4M -7.0% | $235.8M +64.7% | $143.2M +915.7% | $-17.6M -124.3% | $72.4M -53.6% | $155.9M |
Get alerted when AHCO's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for AdaptHealth Corp. including:
Top Institutional Holders of AHCO
OEP CAPITAL ADVISORS, L.P.
$170.0M16,312,698 shBlackRock, Inc.
$167.4M16,061,990 shDEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
$119.6M11,477,730 shSkyKnight Capital, L.P.
$89.4M8,580,443 shFMR LLC
$82.1M7,882,906 shDIMENSIONAL FUND ADVISORS LP
$79.9M7,670,019 shREINHART PARTNERS, LLC.
$77.3M7,415,537 shVANGUARD PORTFOLIO MANAGEMENT LLC
$67.0M6,426,008 shVANGUARD CAPITAL MANAGEMENT LLC
$50.5M4,843,543 shSTATE STREET CORP
$48.2M4,634,476 sh
| Fund | Value | Shares |
|---|---|---|
| OEP CAPITAL ADVISORS, L.P. | $170.0M | 16,312,698 |
| BlackRock, Inc. | $167.4M | 16,061,990 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | $119.6M | 11,477,730 |
| SkyKnight Capital, L.P. | $89.4M | 8,580,443 |
| FMR LLC | $82.1M | 7,882,906 |
| DIMENSIONAL FUND ADVISORS LP | $79.9M | 7,670,019 |
| REINHART PARTNERS, LLC. | $77.3M | 7,415,537 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $67.0M | 6,426,008 |
| VANGUARD CAPITAL MANAGEMENT LLC | $50.5M | 4,843,543 |
| STATE STREET CORP | $48.2M | 4,634,476 |
Companies Similar to AHCO
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
QuidelOrtho Corp
Enovis CORP
INTEGRA LIFESCIENCES HOLDINGS CORP
OLIN Corp
Acadia Healthcare Company, Inc.
Surgery Partners, Inc.
PERRIGO Co plc
DENTSPLY SIRONA Inc.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put AHCO on your watchlist
Track score changes the day AdaptHealth Corp. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is AHCO a good stock to buy?
13F Pro's AI-powered analysis of AdaptHealth Corp. (AHCO) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for AHCO are available on the AHCO stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. AHCO is classified as a small company.
Which hedge funds own AHCO?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling AHCO. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of AdaptHealth Corp.'s investment landscape.